A. H. Loonen

1.4k total citations
28 papers, 1.0k citations indexed

About

A. H. Loonen is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Molecular Biology. According to data from OpenAlex, A. H. Loonen has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Public Health, Environmental and Occupational Health, 14 papers in Hematology and 12 papers in Molecular Biology. Recurrent topics in A. H. Loonen's work include Acute Lymphoblastic Leukemia research (16 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). A. H. Loonen is often cited by papers focused on Acute Lymphoblastic Leukemia research (16 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). A. H. Loonen collaborates with scholars based in Netherlands, United States and Germany. A. H. Loonen's co-authors include A. Veerman, Rob Pieters, D. R. Huismans, Gertjan J.L. Kaspers, K. Hählen, Elisabeth R. van Wering, Peter M. Burch, Ursula Creutzig, Nicholas H. Heintz and Ziqiang Yuan and has published in prestigious journals such as The Lancet, Blood and Molecular and Cellular Biology.

In The Last Decade

A. H. Loonen

27 papers receiving 992 citations

Peers

A. H. Loonen
C. Michel Zwaan Netherlands
Jana Hof Germany
Anders Castor Sweden
Tanja A. Grüber United States
C. Michel Zwaan Netherlands
Valentina Gianfelici Italy
Naval Daver United States
Peter Ernst Saudi Arabia
Anna Grazia Recchia Italy
E. Klumper Netherlands
C. Michel Zwaan Netherlands
A. H. Loonen
Citations per year, relative to A. H. Loonen A. H. Loonen (= 1×) peers C. Michel Zwaan

Countries citing papers authored by A. H. Loonen

Since Specialization
Citations

This map shows the geographic impact of A. H. Loonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. H. Loonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. H. Loonen more than expected).

Fields of papers citing papers by A. H. Loonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. H. Loonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. H. Loonen. The network helps show where A. H. Loonen may publish in the future.

Co-authorship network of co-authors of A. H. Loonen

This figure shows the co-authorship network connecting the top 25 collaborators of A. H. Loonen. A scholar is included among the top collaborators of A. H. Loonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. H. Loonen. A. H. Loonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Poddighe, Pino J., Margreet A. Veening, Marcela Braga Mansur, et al.. (2017). A novel cryptic CBFB-MYH11 gene fusion present at birth leading to acute myeloid leukemia and allowing molecular monitoring for minimal residual disease. Human Pathology Case Reports. 11. 34–38. 2 indexed citations
2.
Poddighe, Pino J., H. Wessels, A. H. Loonen, et al.. (2014). Genomic amplification of MYC as double minutes in a patient with APL-like leukemia. Molecular Cytogenetics. 7(1). 67–67. 11 indexed citations
3.
Ancker, Willemijn van den, Theresia M. Westers, David C. de Leeuw, et al.. (2013). A threshold of 10% for myeloperoxidase by flow cytometry is valid to classify acute leukemia of ambiguous and myeloid origin. Cytometry Part B Clinical Cytometry. 84B(2). 114–118. 35 indexed citations
4.
Goemans, Bianca F., C. Michel Zwaan, Jacqueline Cloos, et al.. (2010). FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657. Leukemia Research. 34(10). 1302–1307. 7 indexed citations
5.
Beverloo, H. Berna, Monique L. den Boer, Renée X. de Menezes, et al.. (2006). Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome. Leukemia. 20(3). 410–416. 35 indexed citations
6.
Kaspers, Gertjan J.L., R. Hartmann, A. H. Loonen, et al.. (2005). Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia. European Journal of Cancer. 41(9). 1300–1303. 24 indexed citations
7.
Goemans, Bianca F., Ch. M. Zwaan, M Zimmermann, et al.. (2005). Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia. Leukemia. 19(9). 1536–1542. 174 indexed citations
8.
Beverloo, H. Berna, A. Veerman, Bruce M. Camitta, et al.. (2004). In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype. Leukemia. 18(3). 521–529. 55 indexed citations
9.
Burch, Peter M., Ziqiang Yuan, A. H. Loonen, & Nicholas H. Heintz. (2004). An Extracellular Signal-Regulated Kinase 1- and 2-Dependent Program of Chromatin Trafficking of c-Fos and Fra-1 Is Required for Cyclin D1 Expression during Cell Cycle Reentry. Molecular and Cellular Biology. 24(11). 4696–4709. 73 indexed citations
10.
Kaaijk, Patricia, Gertjan J.L. Kaspers, Elisabeth R. van Wering, et al.. (2003). Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia. British Journal of Cancer. 88(5). 775–781. 28 indexed citations
11.
Pieters, R., D. Hoelzer, R Släter, et al.. (2002). In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: A report of the Dutch and German Leukemia Study Groups. Medical and Pediatric Oncology. 38(6). 379–386. 18 indexed citations
12.
Valk, Paul van der, et al.. (2002). Features of proliferation and in vitro drug resistance in central primitive neuro‐ectodermal tumours. Neuropathology and Applied Neurobiology. 28(3). 200–209. 2 indexed citations
13.
Klumper, E., R. Pieters, Monique L. den Boer, et al.. (1995). In vitro anthracycline cross-resistance pattern in childhood acute lymphoblastic leukaemia. British Journal of Cancer. 71(6). 1188–1193. 17 indexed citations
14.
Pieters, Rob, Gertjan J.L. Kaspers, Elisabeth R. van Wering, et al.. (1993). Cellular Drug Sensitivity of Immunophenotypic Subgroups of Childhood Acute Lymphoblastic Leukemia. Recent results in cancer research. 131. 249–256. 1 indexed citations
15.
Pieters, Rob, D. R. Huismans, A. H. Loonen, et al.. (1992). Hypoxanthine‐guanine phosphoribosyl‐transferase in childhood leukemia: Relation with immunophenotype, in vitro drug resistance and clinical prognosis. International Journal of Cancer. 51(2). 213–217. 38 indexed citations
16.
Pieters, Rob, D. R. Huismans, A. H. Loonen, et al.. (1992). Relation of 5′-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia. Leukemia Research. 16(9). 873–880. 31 indexed citations
17.
Pieters, Rob, D. R. Huismans, A. H. Loonen, Karel Hählen, & A. Veerman. (1991). Cytotoxic Effects of Vitamin A in Combination with Vincristine, Daunorubicin and 6‐Thioguanine upon Cells from Lymphoblastic Leukemic Patients. Japanese Journal of Cancer Research. 82(9). 1051–1055. 8 indexed citations
18.
Pieters, Rob, et al.. (1991). Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia. The Lancet. 338(8764). 399–403. 175 indexed citations
19.
Schwartsmann, Gilberto, Godefridus J. Peters, E. Laurensse, et al.. (1988). DUP 785 (NSC 368390): Schedule-dependency of growth-inhibitory and antipyrimidine effects. Biochemical Pharmacology. 37(17). 3257–3266. 30 indexed citations
20.
Wulffraat, N. M., et al.. (1985). Bone Marrow Mitotic Index: A Methodological Study. Acta Haematologica. 73(2). 89–92. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Michel Zwaan Breakdown of academic impact, for papers by Jana Hof Breakdown of academic impact, for papers by Anders Castor Breakdown of academic impact, for papers by Tanja A. Grüber Breakdown of academic impact, for papers by C. Michel Zwaan Breakdown of academic impact, for papers by Valentina Gianfelici Breakdown of academic impact, for papers by Naval Daver Breakdown of academic impact, for papers by Peter Ernst Breakdown of academic impact, for papers by Anna Grazia Recchia Breakdown of academic impact, for papers by E. Klumper
Rankless by CCL
2026